Akash Khandelwal

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Transforming Growth Factor

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical and translational science

Antimicrobial agents and chemotherapy

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Denis Menshykau, Jagdev Sidhu, Laura Shaughnessy, Rocio Lledo-Garcia, Pinky Dua, Marie Teil, Akash Khandelwal
Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases. CPT: pharmacometrics & systems pharmacology (2024)
Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Ping Hu, Haiqing Isaac Dai, James Bourdage, Dongli Zhou, Ky Trang, Karey Kowalski, Carlo Bello, Jennifer E Hibma, Akash Khandelwal, Kyra Cowan, Jennifer Dong, Karthik Venkatakrishnan, Wei Gao
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma. Clinical and translational science 17 (3) (2024)
Ana-Marija Milenković-Grišić, Nadia Terranova, Diane R Mould, Yulia Vugmeyster, Thomas Mrowiec, Andreas Machl, Pascal Girard, Karthik Venkatakrishnan, Akash Khandelwal
Tumor growth inhibition modeling in patients with second line biliary tract cancer and first line non-small cell lung cancer based on bintrafusp alfa trials. CPT: pharmacometrics & systems pharmacology (2023)
Han Liu, Ana-Marija Milenković-Grišić, Sreenath M Krishnan, Siv Jonsson, Lena E Friberg, Pascal Girard, Karthik Venkatakrishnan, Yulia Vugmeyster, Akash Khandelwal, Mats O Karlson
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer. CPT: pharmacometrics & systems pharmacology (2023)
Perrine Courlet, Justin J Wilkins, Claude Oeuvray, Wei Gao, Akash Khandelwal
Semi-mechanistic population pharmacokinetic/pharmacodynamic modeling of a Plasmodium elongation factor 2 inhibitor cabamiquine for prevention and cure of malaria. Antimicrobial agents and chemotherapy (2023)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology 12 (2) (2022)
Akash Khandelwal, Ana-Marija Milenković-Grišić, Jonathan L French, Karthik Venkatakrishnan
Pharmacometrics Golems: Exposure-Response Models in Oncology. Clinical pharmacology and therapeutics 112 (5) (2022)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology (2022)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology 12 (2) (2022)
Ana-Marija Milenković-Grišić, Karthik Venkatakrishnan, Jonathan L French, Akash Khandelwal
Variable or variate? A conundrum in pharmacometrics exposure-response models. CPT: pharmacometrics & systems pharmacology 12 (2) (2022)